Nurocor team members will be presenting on Digital Protocol
at the CDISC US Interchange in Scottsdale, Arizona.

Don’t miss the 2024 CDISC+TMF US Interchange Digital Protocol Session Part 2, Bristol Myers Squibb, Nurocor, TransCelerate, and CDISC will discuss how BioPharma companies are advancing Digital Protocols on Wednesday, October 23rd from 3PM-4:30PM (MST) in the North Ballroom.

Topics being presented and discussed include:

• Digital Data Flow and Breaking Down the Document Barrier.
• Transforming Vision into Reality: The Bristol Myers Squibb Journey to embrace the digital protocol

A panel discussion will follow the presentations featuring:

• Viral Vyas (Bristol Myers Squibb, Director of IT for Global Clinical Development)
• Bob Brindle (Nurocor, VP of Product Management)
• Frederik Malfait (Nurocor, SVP Information Architecture)
• Bill Illis (TransCelerate BioPharma/Novartis, Drug Development Informatics & Operations Executive)
• Peter Van Reusel (CDISC, Chief Standards Officer)
• Dave Iberson-Hurst (Partner at d4k)